GREAT POINT PARTNERS LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 116 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2016$5,254,000
-15.2%
978,350
-27.3%
1.50%
-32.3%
Q1 2016$6,193,000
-7.1%
1,346,344
+5.0%
2.22%
-20.6%
Q4 2015$6,669,000
-17.4%
1,282,527
-3.9%
2.80%
-12.4%
Q3 2015$8,077,0001,335,0003.20%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2016
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders